Search results for "Coronavirus"


 
Results 31 - 40 of about 273 for "Coronavirus".
Sort by: Relevance | Newest | Oldest

New COVID-19 treatment recommendations, data on vaccines and delta variant

The NIH updated its recommendations on inpatient treatment to address medication availability, metoprolol showed promise in a small ICU study, and new research highlighted decreased vaccine effectiveness and increased illness severity with the delta variant.
https://acphospitalist.acponline.org/weekly/archives/2021/09/01/1.htm
1 Sep 2021

Dexamethasone use, pandemic cardiac arrests and HAIs, latest COVID-19 vaccine news

Recent studies looked at use of dexamethasone and rates of in-hospital cardiac arrest in COVID-19 patients, hospital-acquired infections (HAIs) during the pandemic, and vaccine-induced immune thrombocytopenia. Also, the FDA and new research supported a third vaccine dose for organ transplant patients.
https://acphospitalist.acponline.org/weekly/archives/2021/08/18/1.htm
18 Aug 2021

New EUA and dose guidelines for COVID-19 released, ACIP reviewed myocarditis reports

The FDA gave an emergency use authorization (EUA) to tocilizumab for inpatients, the NIH revised dosing recommendations on monoclonal antibodies for outpatients, and government experts said myocarditis is extremely rare with the vaccines, among other recent COVID-19 news.
https://acphospitalist.acponline.org/weekly/archives/2021/06/30/1.htm
30 Jun 2021

Latest inpatient COVID-19 research looks at plasma, intubation, delirium, VTE, and more

Recent studies showed that convalescent plasma didn't improve outcomes, a protocol reduced intubation rates, delirium was a common presentation among elderly patients, venous thromboembolism (VTE) was more common in the ICU, and racial disparities persisted after adjustment.
https://acphospitalist.acponline.org/weekly/archives/2020/11/25/2.htm
25 Nov 2020

Mixed findings on remdesivir for COVID-19, news on SARS-CoV-2 vaccines

Among other news this week, the NIH and the WHO released results from remdesivir trials, more negative findings were published for hydroxychloroquine, and ACP and Annals of Internal Medicine held a vaccine forum featuring Anthony S. Fauci, MD, MACP, and other experts.
https://acphospitalist.acponline.org/weekly/archives/2020/10/21/1.htm
21 Oct 2020

Pandemic perspectives–Part 1

The readers of ACP Hospitalist have written about their experiences during the COVID-19 pandemic.
https://acphospitalist.acponline.org/archives/2020/11/pandemic-perspectives-part-1.htm
15 Nov 2020

Pandemic perspectives–Part 3

The readers of ACP Hospitalist have written about their experiences during the COVID-19 pandemic.
https://acphospitalist.acponline.org/archives/2020/11/pandemic-perspectives-part-3.htm
15 Nov 2020

Latest research on COVID-19 antibodies, cardiac and stroke risks, mortality rates

Cardiac effects appeared common while strokes were not, mortality improved, a monoclonal antibody treatment showed benefit in outpatients, and data varied on duration of antibody response, among other recent findings on COVID-19.
https://acphospitalist.acponline.org/weekly/archives/2020/11/04/1.htm
4 Nov 2020

COVID-19 research focused on anticoagulation, vaccine-induced thrombocytopenia

Two new studies support prophylactic, rather than therapeutic, anticoagulation for COVID-19 patients, and case reports provide more information about vaccine-induced immune thrombotic thrombocytopenia.
https://acphospitalist.acponline.org/weekly/archives/2021/06/16/1.htm
16 Jun 2021

Pandemic perspectives–Part 2

The readers of ACP Hospitalist have written about their experiences during the COVID-19 pandemic.
https://acphospitalist.acponline.org/archives/2020/11/pandemic-perspectives-part-2.htm
15 Nov 2020

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next